Credit Suisse Starts Synergy Pharmaceuticals (SGYP) at Outperform
Get Alerts SGYP Hot Sheet
Price: $0.03 --0%
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 42
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 42
Join SI Premium – FREE
Credit Suisse initiates coverage on Synergy Pharmaceuticals (NASDAQ: SGYP) with a Outperform. PT $9.30.
For an analyst ratings summary and ratings history on Synergy Pharmaceuticals click here. For more ratings news on Synergy Pharmaceuticals click here.
Shares of Synergy Pharmaceuticals closed at $4.55 yesterday.
For an analyst ratings summary and ratings history on Synergy Pharmaceuticals click here. For more ratings news on Synergy Pharmaceuticals click here.
Shares of Synergy Pharmaceuticals closed at $4.55 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Starts Valvoline (VVV) at Buy, 'Vintage Brand, New Growth Angle'
- HSBC Downgrades DFI Retail Group Holdings (DFI:SP) (DFILF) to Hold, 'expect H&B to progress more slowly'
- Neogrid Participacoes SA (NGRD3:BZ) PT Lowered to BRL1.20 at Citi, 'combination of stale top-line growth and heavier expenses will keep margins pressured'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!